Corcept Therapeutics Incorporated - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
CORT Nasdaq 2834 www.corcept.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Corcept Therapeutics Incorporated

Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know - Nov 11th, 2025 1:56 pm
We Think You Can Look Beyond Corcept Therapeutics' (NASDAQ:CORT) Lackluster Earnings - Nov 11th, 2025 3:12 am
The 5 Most Interesting Analyst Questions From Corcept’s Q3 Earnings Call - Nov 10th, 2025 10:36 pm
Does Recent Pipeline Progress Justify Corcept’s 53% Rally in 2025? - Nov 6th, 2025 3:10 am
CORT Q3 Deep Dive: Pharmacy Transition and Pipeline Expansion Drive Mixed Outlook - Nov 5th, 2025 6:31 am
Corcept Therapeutics Inc (CORT) Q3 2025 Earnings Call Highlights: Revenue Growth Amidst Net ... - Nov 4th, 2025 10:10 pm
Corcept Therapeutics (CORT) Q3 Earnings and Revenues Miss Estimates - Nov 4th, 2025 4:25 pm
Corcept (NASDAQ:CORT) Reports Sales Below Analyst Estimates In Q3 Earnings - Nov 4th, 2025 4:00 pm
Corcept: Q3 Earnings Snapshot - Nov 4th, 2025 3:20 pm
Corcept Therapeutics Announces Third Quarter Financial Results, Oncology Development Programs and Provides Corporate Update - Nov 4th, 2025 2:05 pm
What Does Wall Street Think About Corcept Therapeutics (CORT)? - Nov 4th, 2025 7:36 am
November 2025's Top Growth Companies With Insider Ownership - Nov 3rd, 2025 10:35 am
Corcept Earnings: What To Look For From CORT - Nov 2nd, 2025 8:04 pm
3 Healthcare Stocks We Steer Clear Of - Oct 30th, 2025 10:42 pm
What Corcept Therapeutics (CORT)'s Phase 3 Relacorilant Data Means for Shareholders - Oct 30th, 2025 6:15 am
NewAmsterdam Pharma Company N.V. (NAMS) Expected to Beat Earnings Estimates: Should You Buy? - Oct 29th, 2025 8:00 am
3 Cash-Producing Stocks with Open Questions - Oct 28th, 2025 10:33 pm
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call - Oct 28th, 2025 2:05 pm
Analysts Estimate Corcept Therapeutics (CORT) to Report a Decline in Earnings: What to Look Out for - Oct 22nd, 2025 8:00 am
Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment - Oct 19th, 2025 3:15 am